The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data-Reference-Cited by-同舟云学术

The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data

Published:2018-07-07 Issue:9 Volume:235 Page:2479-2505
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Rollema Hans^ORCID,Hurst Raymond S.

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s00213-018-4921-9/fulltext.html

Reference90 articles.

1. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 387:2507–2520

2. Arneric S, Anderson DJ, Bannon AW et al (1993) Preclinical pharmacology of ABT-418: a proto-typical cholinergic channel activator for the potential treatment of Alzheimer’s disease. CNS Drug Rev 1:1–26

3. Arneric SP, Holladay M, Williams M (2007) Neuronal nicotinic receptors: a perspective on two decades of drug discovery research. Biochem Pharmacol 74:1092–1101

4. Beckmann JS, Meyer AC, Pivavarchyk M, Horton DB, Zheng G, Smith AM, Wooters TE, McIntosh JM, Crooks PA, Bardo MT, Dwoskin LP (2015) r-bPiDI, an α6β2* nAChR nicotinic receptor antagonist, decreases nicotine-evoked dopamine release and nicotine reinforcement. Neurochem Res 40:2121–2130

5. Benowitz NL (2010) Nicotine addiction. N Engl J Med 362(24):2295–2303

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotinic Receptors of the Neuronal and Non-neuronal Cholinergic Systems as Therapeutic Targets: Opportunities and Limitations;Ion Channels as Targets in Drug Discovery;2024

2. Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the α4β2 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine;Drug and Alcohol Dependence;2023-09

3. Function and pharmacology of neuronal nAChRs;Nicotinic Acetylcholine Receptors in Health and Disease;2023

4. Mechanism of action of cholinergic drugs;How Synthetic Drugs Work;2023

5. Pyrrolidinyl benzofurans and benzodioxanes: Selective α4β2 nicotinic acetylcholine receptor ligands with different activity profiles at the two receptor stoichiometries;Bioorganic & Medicinal Chemistry Letters;2022-06